The global ankylosing spondylitis treatment market is experiencing robust growth, with projections indicating a market value of USD 8.06 billion in 2022 and anticipated to surpass USD 5.1409 billion by 2032, boasting a compound annual growth rate (CAGR) of 4.6% over the forecast period. This upward trajectory reflects advancements in treatment modalities and a deepening understanding of this chronic inflammatory condition.
Ankylosing spondylitis, characterized by its impact on the spine, has witnessed significant therapeutic innovations. Key among these are TNF inhibitor therapies and NSAIDs (Non-steroidal anti-inflammatory drugs), which have emerged as pivotal in managing not only ankylosing spondylitis but also various other inflammatory arthritis conditions. These treatments underscore a pivotal shift towards enhancing patient outcomes and improving quality of life.
Get a PDF Sample with Latest Market Insights: https://www.futuremarketinsights.com/reports/sample/rep-gb-12345
Despite these advancements, challenges persist, as underscored by recent studies and findings. The landscape continues to evolve, necessitating ongoing research and development efforts to address unmet needs and optimize treatment efficacy.
“We are witnessing a transformative phase in the management of ankylosing spondylitis,” said FMI. “As market leaders, we remain committed to driving innovation and delivering solutions that make a meaningful difference in the lives of patients worldwide.”
Key Takeaways from Ankylosing Spondylitis Treatment Market Study
- Nonsteroidal anti-inflammatory drugs lead the market as they are looked upon as the first line of treatment for ankylosing spondylitis
- Oral route of administration holds the largest market share due to simplicity of consumption.
- By age group, “adults” contribute to majority of revenue generation as ankylosing spondylitis usually gets initiated in adulthood.
- North America, led by the US, holds the highest market share due to well-established healthcare infrastructure, high incidences of ankylosing spondylitis, and innovations in pharmaceutical industry.
For More Report Customization: https://www.futuremarketinsights.com/customization-available/rep-gb-12345
Ankylosing Spondylitis Treatment Market Trends:
The healthcare sector is increasingly focused on advancing research into ankylosing spondylitis, aiming to drive innovation forward.
For example:
- In July 2020, researchers at Rockefeller University identified “PRIME cells” capable of suppressing inflammation associated with rheumatoid arthritis, offering potential insights into managing flares of this condition. This breakthrough is expected to pave the way for the development of biosimilars to treat such forms of spondylitis before they progress to advanced stages.
- In June 2020, Celltrion Healthcare received a recommendation from the Committee for Medicinal Products for Human Use (CHMP) for the use of Remsima in ankylosing spondylitis.
- In October 2019, the Spondylitis Association of America (SAA) partnered with PatientPoint to enhance education about spondylitis and support rheumatology practices across the United States.
Major Players in the Ankylosing Spondylitis Treatment Market:
- Wyeth
- Mitsubishi Tanabe
- Schering-Plough
- Takeda
- Amgen
- Centocor
- Abbott
- Eisai
- Pfizer
Key Segment:
Drug Class
- Nonsteroidal Anti-inflammatory Drugs
- Anti-Inflammatory Drugs
- Immunosuppressive Drugs
- TNF Blockers
- JAK Inhibitors
- Steroids
- Biologics
- Others
Route of Administration
- Parenteral
- Oral
Application
- Adults
- Juveniles
Region
- North America
- Latin America
- Europe
- East Asia
- South Asia
- Oceania
- Middle East and Africa
Full Report Now: https://www.futuremarketinsights.com/checkout/12345
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
